Publication | Closed Access

Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU

Neuro-oncologyNew 2-Chloroethylnitrosourea CongenersBiochemistryAmino AcidMedicineAnti-cancer AgentHuman GliomaDrug DevelopmentPharmacologyGliomaDrug Discovery